| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.36 | 0.0004 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.37 | 0.002 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.29 | 0.01 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.28 | 0.02 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.074 | 0.02 |